BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1

Historical Portfolio Holders from Q2 2021 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Debt / NOTE 1.250% 5/1
Principal, excl. options Q1 2024
390 M
Holdings value Q1 2024
$387 M
Value change Q1 2024
+$12 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
55
Number of buys Q1 2024
16
Number of sells Q1 2024
-20
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
09061GAK7
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q1 $390 M $387 M +$12 M $0.99 55
2023 Q4 $382 M $394 M +$14.8 M $1.03 55
2023 Q3 $301 M $300 M +$15.1 M $0.99 46
2023 Q2 $362 M $366 M +$30.2 M $1.01 47
2023 Q1 $333 M $347 M +$77.6 M $1.04 44
2022 Q4 $257 M $283 M +$42.3 M $1.08 44
2022 Q3 $206 M $177 M -$103 M $1.00 35
2022 Q2 $320 M $282 M -$9.9 M $0.99 34
2022 Q1 $323 M $295 M +$130 M $1.00 28
2021 Q4 $195 M $172 M -$31.4 M $1.04 31
2021 Q3 $249 M $436 M +$2.61 M $1.00 26
2021 Q2 $244 M $247 M +$247 M $1.00 28